Renal Denervation Market Report Statistics

• Global renal denervation market revenue is estimated to reach USD 4,464.6 Million by 2030 with a CAGR of 41.5% from 2022 to 2030
• Europe renal denervation market share accounted for over 70% shares in 2021
• According to World Health Organization (WHO), more than 1.1 billion people suffer from hypertension throughout the world
• Asia-Pacific renal denervation market growth will register quick CAGR from 2022 to 2030
• Based on product type, symplicity acquired over 45% of the overall market share in 2021
• Associated beneficial factors will fuel the global renal denervation market value
• Development of new techniques is a popular renal denervation market trend that is fueling the industry demand

The global renal denervation market in developed economies, such as Italy, the U.K., and France, is moderately mature as compared to other developing and under-developed economies attributable to the presence of major companies in these countries and high awareness and demand among the population for such products. Europe constituted the largest share due to the technological advancements and increase in number of drug-resistant hypertension cases in the regional market.

Global Renal Denervation Market Dynamics

Market Drivers

• Increasing prevalence of hypertension
• Long-lasting effect of procedure
• Changing lifestyle of people
• Availability of improved and alternative technology

Market Restraints

• Negative reimbursement and painful procedure
• Strict regulatory framework for these devices

Market Opportunities

• Technological advancement in renal denervation devices
• Growing expenditure on research and clinical activities

Renal Denervation Market Report Coverage

Renal Denervation Market Growth Factors

Availability of improved and alternative technology, such as micro-infusion, for renal denervation systems and better healthcare infrastructures in emerging economies are also expected to enhance market growth. For instance, Mercator MedSystem’s micro-infusion based renal denervation system reduces the blood pressure in patients, by delivering to its agents at a specific site to denervate the renal artery.

Renal Denervation Market Insights

In 2013, according to the Centers for Disease Control and Prevention (CDC), over 3.6lakh people in the U.S. died because of high blood pressure. The occurrence of hypertension has augmented from 17,307 per 100,000 in 1990 to 20,525 per 100,000 in 2015. However, the renal denervation therapy has also shown a optimistic result in minimizing hypertension. Consequently, the advantages offered by such therapies, for instance reduced treatment time, higher safety, and permanent effects are boosting the market growth. Moreover, technological advancement in renal denervation devices is likely to drive the market.

Renal Denervation Market Segmentation

The global renal denervation market is segmented based on product type, technology, indication, end-user, and geography.

Renal Denervation Market By Product Type

• Symplicity
• Enlightn
• Vessix
• Paradise
• Iberis
• Others

Renal Denervation Market By Technology

• Radiofrequency
• Ultrasound
• Micro-Infusion

Renal Denervation Market By Indication

• Hypertension
• Heart Failure
• Diabetes
• Renal Failure

Renal Denervation Market By End-User

• Hospitals
• Specialty Clinics
• Others

Renal Denervation Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Renal Denervation Market Regional Analysis

In 2021, Europe led the renal denervation market in terms of regions and is anticipated to maintain the dominance even during the forecast period. North America renal denervation market is projected to follow Europe, in terms of revenue generation, during the forecast period due to the increasing number of filings for FDA approvals in the U.S. Rising occurrence of uncontrolled hypertension is also one of the key factors responsible for the North America renal denervation market growth. Asia-Pacific renal denervation market is anticipated to experience the fastest growth over the forecast period owing to rising cases of obesity, diabetes, and other lifestyle related diseases. Also, the presence of a large target population base in developing economies like China and Japan are the main drivers for the market growth in Asia-Pacific region.

Renal Denervation Market Players

The key players catering to the global renal denervation market are Medtronic PLC, Cardiosonic, Inc., Kona Medical, Inc., Abbott Laboratories, Ablative Solutions, Inc., Renal Dynamics, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corp., and Symple Surgical, Inc. The global players are continuously investing in R&D activities and innovating to have updated technology-based product portfolio to attract more and more business opportunity from the emerging nation such as that in Asia Pacific countries.

In April 2021, Medtronic collaborated with Surgical Theater, a developer of technology for patients based on fighter aircraft flight simulation. As a result of this collaboration, Medtronic will integrate the Surgical Theater's SyncAR Augmented Reality technology with StealthStation S8 Surgical Navigation System, allowing neurosurgeons to use real-time AR technology to improve visualisation during difficult cranial surgery.